These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 336109)

  • 1. Positive cross-match for B-lymphocyte antigens (IA like) and kidney allograft behaviour.
    Soulillou JP; Guenel J; Peyrat MA
    Biomedicine; 1977 Jul; 27(5):183-4. PubMed ID: 336109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-B lymphocytotoxins in renal-allograft rejection.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
    N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of T and B cells flow-cross matches in renal transplant recipients.
    C LK; Kamaraju SR; Kancherla R
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):571-3. PubMed ID: 18580015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cross test with B-lymphocytes in transplantation immunology].
    Laurentaci G; Catalano G; Favoino B; Memeo V; Selvaggi FP; Traficante A
    Minerva Chir; 1980 May; 35(10):695-9. PubMed ID: 7005723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presensitization to donor B-cell ("Ia") antigens is associated with early allograft failures.
    Suthanthiran M; Gailiunas P; St Louis G; Fagan G; Carpenter CB; Garovoy MR
    Transplant Proc; 1977 Dec; 9(4):1807-9. PubMed ID: 341440
    [No Abstract]   [Full Text] [Related]  

  • 8. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens.
    Suthanthiran M; Gailiunas P; Person A; Fagan G; Strom TB; Carpenter CB; Garovoy MR
    Transplant Proc; 1978 Jun; 10(2):471-3. PubMed ID: 354138
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunobiological determinants in organ transplantation.
    Marks C
    Ann R Coll Surg Engl; 1983 May; 65(3):139-44. PubMed ID: 6344730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
    Nunez G; McPhaul J; Stastny P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients.
    Akalin E; Ames S; Sehgal V; Fotino M; Daly L; Murphy B; Bromberg JS
    Transplantation; 2003 Nov; 76(10):1444-7. PubMed ID: 14657683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 14. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection.
    Jordan SC; Vo AA; Toyoda M; Tyan D; Nast CC
    Pediatr Transplant; 2005 Apr; 9(2):155-61. PubMed ID: 15787786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one-center study.
    Hourmant M; Bignon JD; Cesbron A; Soulillou JP
    Clin Transpl; 1990; ():301-9. PubMed ID: 2103154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immunity after clinical renal transplantation.
    Arnesen E; Bondevik H; Thorsby E
    Proc Eur Dial Transplant Assoc; 1975; 11():343-50. PubMed ID: 1105555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR typing and B cell cross-match tests in cadaveric renal transplantation.
    Albrechtsen D; Flatmark A; Halvorsen S; Jervell J; Solheim BG; Thorsby E
    Scand J Urol Nephrol Suppl; 1980; 54():25-8. PubMed ID: 7013036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients.
    Ettenger RB; Opelz G; Walker J; Terasaki PI; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    Transplant Proc; 1978 Jun; 10(2):479-81. PubMed ID: 150082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.